Innovex International (INVX) Financials

$15.88 +0.61 (+3.99%)

As of 04/17/2025 03:58 PM Eastern

Annual Income Statements for Innovex International

This table shows Innovex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	209	192	93	-101	-96	1.72	-31	-128	63	74	140
Consolidated Net Income / (Loss)	209	192	93	-101	-96	1.72	-31	-128	63	74	140
Net Income / (Loss) Continuing Operations	209	192	93	-101	-96	1.72	-31	-128	63	74	140
Total Pre-Tax Income	279	250	116	-66	-115	10	-62	-126	73	94	143
Total Operating Income	279	249	113	-69	-123	2.80	-64	-125	76	97	49
Total Gross Profit	417	385	210	125	91	120	95	13	158	195	233
Total Revenue	931	844	539	455	385	415	365	322	467	556	661
Operating Revenue	931	844	539	455	385	415	365	322	467	556	661
Total Cost of Revenue	514	459	328	330	294	295	270	309	309	360	428
Operating Cost of Revenue	514	459	328	330	294	-	270	309	309	360	428
Total Operating Expenses	139	136	97	194	214	117	159	139	82	98	184
Selling, General & Admin Expense	93	88	53	114	102	98	95	115	59	73	116
Depreciation Expense	-	-	-	-	-	-	-	-	18	23	31
Other Operating Expenses / (Income)	-	-	-	-	-1.01	-1.63	2.35	0.84	2.94	2.33	33
Impairment Charge	-	0.00	-	61	39	0.00	7.72	-	0.96	0.27	3.52
Other Special Charges / (Income)	-	-	-0.10	-0.17	-6.20	-1.51	-0.59	-4.48	0.71	0.11	-0.65
Total Other Income / (Expense), net	0.63	0.94	3.01	3.49	7.75	7.63	1.51	-0.21	-2.91	-2.92	94
Interest Expense	0.04	0.01	0.03	0.07	0.29	0.31	0.62	0.21	4.03	5.51	2.43
Interest & Investment Income	0.67	0.95	3.04	3.56	8.04	7.94	2.13	-	0.00	2.98	11
Other Income / (Expense), net	-	-	-	-	-	-	-	-	1.12	-0.39	86
Income Tax Expense	71	58	23	35	-19	8.71	-31	2.95	9.65	20	2.49
Basic Earnings per Share	$5.22	$5.00	$2.48	($2.69)	($2.58)	$0.05	($0.87)	($3.63)	$2.07	$2.39	$2.82
Weighted Average Basic Shares Outstanding	39.96M	38.36M	37.54M	37.46M	37.08M	35.84M	35.26M	35.33M	30.54M	30.93M	49.73M
Diluted Earnings per Share	$5.19	$4.98	$2.47	($2.69)	($2.58)	$0.05	($0.87)	($3.63)	$2.01	$2.29	$2.77
Weighted Average Diluted Shares Outstanding	40.19M	38.53M	37.67M	37.46M	37.08M	36.15M	35.26M	35.33M	31.44M	32.34M	50.63M
Weighted Average Basic & Diluted Shares Outstanding	40M	38.40M	37.60M	37.40M	36.39M	35.87M	35.43M	34.79M	34.17M	34.41M	69.26M

This table shows Innovex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	13	64	2.31	3.48	15	54	-20	-1.81	83	80
Consolidated Net Income / (Loss)	13	64	2.31	3.48	15	53	-20	-1.81	83	80
Net Income / (Loss) Continuing Operations	13	64	2.31	3.48	15	53	-20	-1.81	83	80
Total Pre-Tax Income	13	69	5.94	5.59	23	60	-17	-2.61	80	82
Total Operating Income	12	73	3.19	3.61	24	67	-19	-4.67	-13	86
Total Gross Profit	22	92	25	24	50	96	32	37	53	111
Total Revenue	88	202	91	90	139	236	110	120	152	278
Operating Revenue	88	202	91	90	139	236	110	120	152	278
Total Cost of Revenue	66	110	66	66	89	140	78	83	99	167
Operating Cost of Revenue	66	110	66	66	89	140	78	83	99	167
Total Operating Expenses	10	19	22	20	26	30	51	42	66	25
Selling, General & Admin Expense	22	-8.13	23	22	19	8.87	30	30	38	18
Other Operating Expenses / (Income)	-1.90	8.51	1.12	-3.68	0.76	4.13	17	8.37	20	-13
Other Special Charges / (Income)	-17	18	-6.65	-0.74	-	-	-0.20	0.05	-0.17	-0.34
Total Other Income / (Expense), net	0.25	-3.79	2.75	1.98	-0.63	-7.01	2.20	2.05	93	-3.73
Interest Expense	-0.25	4.13	-2.75	-1.98	1.52	8.72	-2.20	-2.05	0.73	5.95
Income Tax Expense	-0.61	4.59	3.62	2.10	7.88	6.83	3.38	-0.80	-2.59	2.50
Basic Earnings per Share	$0.39	$2.10	$0.07	$0.10	$0.50	$1.72	($0.58)	($0.05)	$2.03	$1.42
Weighted Average Basic Shares Outstanding	33.95M	30.54M	34.13M	34.13M	30.93M	30.93M	34.42M	34.44M	40.73M	49.73M
Diluted Earnings per Share	$0.38	$2.05	$0.07	$0.10	$0.48	$1.64	($0.58)	($0.05)	$1.99	$1.41
Weighted Average Diluted Shares Outstanding	34.23M	31.44M	34.49M	34.49M	32.08M	32.34M	34.42M	34.44M	41.53M	50.63M
Weighted Average Basic & Diluted Shares Outstanding	33.92M	34.17M	34.17M	34.18M	34.18M	34.41M	34.42M	34.45M	67.25M	69.26M

This table details how cash moves in and out of Innovex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-86	83	42	64	-69	-19	-53	9.50	-1.32	-1.01	66
Net Cash From Operating Activities	149	190	247	108	46	15	-21	38	-5.81	76	93
Net Cash From Continuing Operating Activities	149	190	247	108	46	15	-21	38	-5.81	76	93
Net Income / (Loss) Continuing Operations	209	192	93	-101	-96	1.72	-31	-128	63	74	140
Consolidated Net Income / (Loss)	209	192	93	-101	-96	1.72	-31	-128	63	74	140
Depreciation Expense	31	30	32	41	35	34	32	30	18	23	31
Amortization Expense	-	-	-	-	-	-	-	-	6.80	7.73	8.73
Non-Cash Adjustments To Reconcile Net Income	11	13	12	95	76	-45	56	56	-1.53	1.09	-78
Changes in Operating Assets and Liabilities, net	-102	-45	109	73	30	24	-78	80	-93	-30	-9.30
Net Cash From Investing Activities	-42	-27	-158	-45	-15	-8.47	-5.63	-3.21	-38	-32	78
Net Cash From Continuing Investing Activities	-42	-27	-158	-45	-15	-8.47	-5.63	-3.21	-38	-32	78
Purchase of Property, Plant & Equipment	-43	-27	-26	-28	-32	-12	-12	-9.99	-9.58	-15	-14
Acquisitions	0.00	0.00	-132	-20	-	-	-	0.00	-29	-18	-66
Sale of Property, Plant & Equipment	0.98	0.42	0.36	3.17	17	3.03	6.32	6.78	0.97	1.41	3.25
Divestitures	-	-	-	-	-	-	-	-	0.00	0.00	154
Net Cash From Financing Activities	-187	-74	-22	0.56	-99	-25	-25	-24	42	-45	-103
Net Cash From Continuing Financing Activities	-187	-74	-22	0.56	-99	-25	-25	-24	42	-45	-103
Repayment of Debt	-	-	0.00	-	-0.82	-0.18	-0.18	-0.11	-83	-290	-197
Repurchase of Common Equity	-190	-76	-24	-	-100	-27	-25	-24	-1.29	0.00	0.00
Payment of Dividends	-	-	-	-	-	-	-	-	0.00	0.00	-75
Issuance of Debt	-	-	-	-	-	-	-	-	132	255	187
Other Financing Activities, net	3.41	2.24	2.34	0.56	1.62	2.18	-	-	-5.68	-9.27	-19
Effect of Exchange Rate Changes	-6.57	-7.30	-25	-	-	-0.79	-1.09	-1.43	-0.27	0.12	-2.94
Cash Interest Paid	-	-	-	-	-	-	-	-	3.15	5.75	1.99
Cash Income Taxes Paid	-	-	-	-	-	-	-	-	15	28	5.60

This table details how cash moves in and out of Innovex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-31	64	-29	1.15	28	-0.90	11	-13	95	-27
Net Cash From Operating Activities	1.04	13	-53	11	96	21	-4.10	-9.30	71	36
Net Cash From Continuing Operating Activities	1.04	13	-53	11	96	21	-4.10	-9.30	71	36
Net Income / (Loss) Continuing Operations	13	64	2.31	3.48	50	18	-20	-1.81	130	32
Consolidated Net Income / (Loss)	13	64	2.31	3.48	50	18	-20	-1.81	130	32
Depreciation Expense	7.12	-3.88	6.89	7.05	2.64	6.08	8.43	8.01	2.73	12
Amortization Expense	-	-	-	-	-	1.95	-	-	-	2.66
Non-Cash Adjustments To Reconcile Net Income	-24	41	-9.76	13	-2.52	0.34	25	2.74	-105	0.46
Changes in Operating Assets and Liabilities, net	4.63	-95	-52	-12	41	-5.43	-17	-18	37	-11
Net Cash From Investing Activities	-18	-17	23	-9.28	-46	-0.82	18	-2.01	135	-72
Net Cash From Continuing Investing Activities	-18	-17	23	-9.28	-46	-0.82	18	-2.01	135	-72
Purchase of Property, Plant & Equipment	-10	4.14	-5.42	-10	1.27	-1.14	-4.76	-6.16	4.95	-7.63
Acquisitions	-	-29	0.00	-	-18	-	0.00	-	-	-66
Sale of Property, Plant & Equipment	18	-18	15	0.78	-15	0.32	0.38	0.13	1.55	1.19
Net Cash From Financing Activities	-11	63	-0.01	-0.01	-23	-22	-0.30	-0.18	-114	11
Net Cash From Continuing Financing Activities	-11	63	-0.01	-0.01	-23	-22	-0.30	-0.18	-114	11
Repayment of Debt	0.01	-83	-0.01	-0.01	-215	-75	-0.30	-0.18	-171	-25
Issuance of Debt	-	-	-	-	-	56	-	-	-	39
Other Financing Activities, net	-	-	-	-	-	-2.38	-	-	-	-2.86
Effect of Exchange Rate Changes	-2.79	4.39	0.12	-0.84	0.77	0.07	-2.21	-1.59	3.01	-2.15
Cash Interest Paid	-	-	-	-	-	1.97	-	-	-	0.43
Cash Income Taxes Paid	-	-	-	-	-	46	-	-	-	13

This table presents Innovex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,449	1,428	1,461	1,400	1,193	1,207	1,151	1,010	970	475	1,197
Total Current Assets	1,127	1,124	1,057	1,009	853	880	863	746	750	288	641
Cash & Equivalents	299	381	423	493	418	399	346	355	259	7.41	73
Accounts Receivable	374	320	214	192	202	248	257	204	235	118	240
Inventories, net	393	344	355	291	191	205	213	146	146	141	271
Prepaid Expenses	38	54	-	-	-	-	-	9.62	20	21	48
Other Current Assets	-	-	40	33	42	28	48	31	32	0.00	5.06
Other Current Nonoperating Assets	-	-	-	-	-	-	-	0.00	19	0.00	4.75
Plant, Property, & Equipment, net	310	294	323	284	274	258	235	216	181	52	191
Total Noncurrent Assets	13	9.70	82	107	65	68	53	49	39	135	365
Long-Term Investments	-	-	-	-	-	-	-	-	-	20	0.00
Goodwill	-	0.00	34	48	7.71	7.95	-	-	0.00	24	60
Intangible Assets	-	0.00	30	38	35	32	29	26	23	42	108
Noncurrent Deferred & Refundable Income Taxes	-	0.00	1.70	5.36	8.00	8.94	5.77	11	4.49	14	135
Other Noncurrent Operating Assets	13	9.70	16	16	15	18	18	11	11	35	62
Total Liabilities & Shareholders' Equity	1,449	1,428	1,461	1,400	1,193	1,207	1,151	1,010	970	475	1,197
Total Liabilities	204	104	105	105	96	116	110	113	98	146	239
Total Current Liabilities	199	101	101	100	82	97	86	94	88	79	163
Short-Term Debt	-	-	-	-	-	-	-	-	-	9.82	10
Accounts Payable	54	31	36	33	27	46	37	35	43	32	65
Accrued Expenses	35	19	18	26	32	24	26	37	19	29	61
Current Deferred Revenue	71	18	12	4.77	9.65	6.90	11	9.75	8.02	0.00	13
Other Current Liabilities	-	-	-	-	-	1.31	1.11	1.05	1.05	8.03	13
Total Noncurrent Liabilities	5.42	2.98	3.50	5.43	15	19	24	20	10	68	77
Long-Term Debt	-	-	-	-	-	-	-	-	-	41	25
Noncurrent Deferred & Payable Income Tax Liabilities	5.42	2.98	3.50	3.43	2.47	4.15	6.78	3.93	3.76	0.00	0.62
Other Noncurrent Operating Liabilities	0.00	0.00	0.00	2.00	2.72	5.91	7.97	6.10	5.47	27	51
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,245	1,324	1,356	1,294	1,096	1,091	1,042	897	872	329	958
Total Preferred & Common Equity	1,245	1,324	1,356	1,294	1,096	1,091	1,042	897	872	329	958
Preferred Stock	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,245	1,324	1,356	1,294	1,096	1,091	1,042	897	872	329	958
Common Stock	17	0.38	5.84	20	35	53	66	81	91	181	756
Retained Earnings	1,279	1,425	1,501	1,400	1,206	1,181	1,125	973	950	146	211
Accumulated Other Comprehensive Income / (Loss)	-50	-101	-150	-126	-145	-144	-150	-157	-169	2.07	-8.86

This table presents Innovex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	971	975	980	1,008	1,021	1,008	1,133
Total Current Assets	746	752	755	709	715	708	677
Cash & Equivalents	290	235	236	181	198	186	100
Accounts Receivable	220	282	275	288	277	287	225
Inventories, net	141	153	165	183	209	205	298
Prepaid Expenses	-	16	19	19	13	17	45
Other Current Assets	49	36	31	18	8.29	8.01	8.15
Other Current Nonoperating Assets	20	11	11	11	1.51	1.51	1.54
Plant, Property, & Equipment, net	181	183	186	212	215	211	182
Total Noncurrent Assets	43	40	39	87	91	89	273
Long-Term Investments	-	-	-	-	-	-	20
Goodwill	-	-	-	16	16	16	24
Intangible Assets	24	23	22	43	40	39	36
Noncurrent Deferred & Refundable Income Taxes	8.89	4.85	4.37	5.84	9.66	10	139
Other Noncurrent Operating Assets	11	12	12	22	24	24	55
Total Liabilities & Shareholders' Equity	971	975	980	1,008	1,021	1,008	1,133
Total Liabilities	106	95	100	137	164	156	228
Total Current Liabilities	89	83	88	107	134	126	175
Short-Term Debt	-	-	-	-	-	-	11
Accounts Payable	46	47	54	50	63	61	84
Accrued Expenses	22	14	13	25	40	37	56
Current Deferred Revenue	8.86	7.27	6.01	8.10	6.84	7.96	14
Other Current Liabilities	1.01	1.23	1.12	2.06	2.30	2.45	11
Total Noncurrent Liabilities	16	12	12	30	30	29	54
Long-Term Debt	-	-	-	-	-	-	12
Noncurrent Deferred & Payable Income Tax Liabilities	3.92	4.03	4.51	12	10	9.19	0.00
Other Noncurrent Operating Liabilities	5.98	6.76	6.64	18	19	20	41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	865	880	879	870	857	853	904
Total Preferred & Common Equity	865	880	879	870	857	853	904
Total Common Equity	865	880	879	870	857	853	904
Common Stock	88	93	96	99	103	107	723
Retained Earnings	953	955	956	949	931	929	179
Accumulated Other Comprehensive Income / (Loss)	-176	-168	-172	-177	-177	-183	1.71

This table displays calculated financial ratios and metrics derived from Innovex International's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.72%	-9.31%	-36.19%	-15.46%	-15.55%	7.85%	-12.01%	-11.65%	44.89%	18.91%	18.95%
EBITDA Growth	22.55%	-9.87%	-48.19%	-119.46%	-210.44%	142.12%	-184.65%	-204.63%	207.67%	24.51%	37.11%
EBIT Growth	24.69%	-10.73%	-54.65%	-161.26%	-77.53%	102.28%	-2,367.53%	-97.19%	161.41%	25.90%	38.90%
NOPAT Growth	22.92%	-8.14%	-52.53%	-153.30%	-77.53%	100.54%	-9,724.24%	-97.19%	175.01%	15.81%	-36.73%
Net Income Growth	22.90%	-8.00%	-51.45%	-207.96%	4.91%	101.80%	-1,888.84%	-317.62%	149.25%	16.83%	89.82%
EPS Growth	24.76%	-4.05%	-50.40%	-208.91%	4.09%	101.94%	-1,840.00%	-317.24%	155.37%	13.93%	20.96%
Operating Cash Flow Growth	-7.96%	27.35%	29.64%	-56.19%	-57.86%	-67.74%	-243.67%	282.23%	-115.12%	1,405.52%	23.17%
Free Cash Flow Firm Growth	-1.30%	63.01%	-48.12%	-17.57%	-55.19%	-135.47%	-265.13%	237.00%	-22.14%	443.88%	-283.90%
Invested Capital Growth	10.36%	-0.36%	-1.08%	-14.11%	-15.38%	2.02%	0.55%	-22.13%	2.64%	-36.70%	160.17%
Revenue Q/Q Growth	2.46%	-5.93%	-15.06%	-56.27%	299.61%	2.75%	-23.56%	0.21%	78.40%	33.47%	35.70%
EBITDA Q/Q Growth	5.38%	-6.25%	-30.62%	-1.79%	-1,691.59%	154.64%	-153.81%	-175.36%	361.42%	145.24%	696.35%
EBIT Q/Q Growth	5.71%	-6.72%	-36.53%	-0.69%	-320.11%	102.75%	-38.57%	-93.39%	211.25%	242.90%	316.45%
NOPAT Q/Q Growth	6.13%	-5.42%	-34.42%	-0.69%	-320.11%	100.65%	-38.57%	-93.39%	235.89%	362.96%	176.10%
Net Income Q/Q Growth	6.11%	-5.29%	-33.54%	-261.37%	-3.71%	102.13%	-153.99%	-69.47%	197.14%	256.18%	248.77%
EPS Q/Q Growth	6.79%	-4.05%	-33.42%	-258.67%	-4.45%	102.29%	-163.64%	-68.84%	208.65%	257.81%	279.45%
Operating Cash Flow Q/Q Growth	20.45%	-7.45%	-2.53%	8.25%	-30.91%	-24.81%	-662.05%	126.69%	59.86%	105.73%	803.49%
Free Cash Flow Firm Q/Q Growth	51.67%	-10.94%	-55.61%	174.83%	-64.57%	-181.12%	-56.20%	132.88%	91.47%	326.16%	-158.02%
Invested Capital Q/Q Growth	1.21%	2.64%	12.43%	-10.27%	-11.62%	1.79%	2.53%	-10.41%	5.04%	-47.45%	13.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.84%	45.60%	39.04%	27.49%	23.67%	28.88%	26.10%	4.09%	33.84%	35.18%	35.20%
EBITDA Margin	33.29%	33.08%	26.86%	-6.18%	-22.73%	8.88%	-8.54%	-29.45%	21.88%	22.91%	26.41%
Operating Margin	29.94%	29.47%	20.95%	-15.18%	-31.91%	0.68%	-17.41%	-38.87%	16.23%	17.51%	7.43%
EBIT Margin	29.94%	29.47%	20.95%	-15.18%	-31.91%	0.68%	-17.41%	-38.87%	16.47%	17.44%	20.37%
Profit (Net Income) Margin	22.42%	22.74%	17.30%	-22.10%	-24.88%	0.41%	-8.43%	-39.85%	13.54%	13.31%	21.24%
Tax Burden Percent	74.71%	76.87%	80.45%	153.31%	83.22%	16.49%	49.59%	102.35%	86.77%	78.34%	98.26%
Interest Burden Percent	100.23%	100.38%	102.67%	94.95%	93.69%	372.07%	97.62%	100.17%	94.76%	97.39%	106.11%
Effective Tax Rate	25.29%	23.13%	19.55%	0.00%	0.00%	83.51%	0.00%	0.00%	13.23%	21.66%	1.74%
Return on Invested Capital (ROIC)	23.08%	20.25%	9.68%	-5.58%	-11.62%	0.07%	-6.41%	-14.18%	11.99%	16.79%	7.61%
ROIC Less NNEP Spread (ROIC-NNEP)	22.95%	20.03%	9.08%	5.82%	-9.47%	-0.24%	-10.10%	-2.56%	12.74%	18.35%	-927.46%
Return on Net Nonoperating Assets (RNNOA)	-6.30%	-5.30%	-2.73%	-2.01%	3.61%	0.09%	3.53%	0.93%	-4.84%	-4.48%	14.20%
Return on Equity (ROE)	16.78%	14.94%	6.95%	-7.59%	-8.01%	0.16%	-2.89%	-13.26%	7.15%	12.31%	21.81%
Cash Return on Invested Capital (CROIC)	13.24%	20.60%	10.77%	9.60%	5.04%	-1.93%	-6.96%	10.70%	9.39%	61.74%	-81.33%
Operating Return on Assets (OROA)	19.59%	17.30%	7.81%	-4.83%	-9.47%	0.23%	-5.39%	-11.60%	7.77%	13.41%	16.09%
Return on Assets (ROA)	14.67%	13.35%	6.45%	-7.03%	-7.38%	0.14%	-2.61%	-11.89%	6.39%	10.23%	16.78%
Return on Common Equity (ROCE)	16.78%	14.94%	6.95%	-7.59%	-8.01%	0.16%	-2.89%	-13.26%	7.15%	12.31%	21.81%
Return on Equity Simple (ROE_SIMPLE)	16.76%	14.50%	6.87%	-7.77%	-8.73%	0.16%	-2.95%	-14.32%	7.25%	22.48%	14.65%
Net Operating Profit after Tax (NOPAT)	208	191	91	-48	-86	0.46	-44	-88	66	76	48
NOPAT Margin	22.37%	22.66%	16.85%	-10.63%	-22.34%	0.11%	-12.19%	-27.21%	14.09%	13.72%	7.30%
Net Nonoperating Expense Percent (NNEP)	0.14%	0.21%	0.60%	-11.40%	-2.15%	0.31%	3.68%	-11.62%	-0.75%	-1.56%	935.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	7.54%	20.09%	4.85%
Cost of Revenue to Revenue	55.16%	54.40%	60.96%	72.51%	76.33%	71.12%	73.90%	95.91%	66.16%	64.82%	64.80%
SG&A Expenses to Revenue	9.96%	10.43%	9.88%	24.94%	26.54%	23.72%	26.04%	35.68%	12.67%	13.10%	17.58%
R&D to Revenue	4.93%	5.70%	8.23%	4.39%	5.28%	4.18%	5.18%	4.68%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.90%	16.13%	18.09%	42.67%	55.58%	28.21%	43.52%	42.96%	17.61%	17.67%	27.78%
Earnings before Interest and Taxes (EBIT)	279	249	113	-69	-123	2.80	-64	-125	77	97	135
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	310	279	145	-28	-87	37	-31	-95	102	127	175
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.43	1.72	1.66	1.40	0.98	1.56	1.00	0.78	1.06	2.42	0.98
Price to Tangible Book Value (P/TBV)	2.43	1.72	1.75	1.49	1.02	1.62	1.03	0.80	1.09	3.02	1.19
Price to Revenue (P/Rev)	3.25	2.69	4.19	3.97	2.79	4.09	2.85	2.16	1.97	1.43	1.42
Price to Earnings (P/E)	14.51	11.83	24.21	0.00	0.00	986.76	0.00	0.00	14.56	10.76	6.69
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.89%	8.45%	4.13%	0.00%	0.00%	0.10%	0.00%	0.00%	6.87%	9.29%	14.94%
Enterprise Value to Invested Capital (EV/IC)	2.88	2.00	1.97	1.64	0.97	1.88	1.00	0.63	1.12	2.33	0.98
Enterprise Value to Revenue (EV/Rev)	2.93	2.24	3.40	2.88	1.71	3.13	1.90	1.06	1.34	1.47	1.36
Enterprise Value to EBITDA (EV/EBITDA)	8.81	6.77	12.67	0.00	0.00	35.26	0.00	0.00	6.11	6.43	5.17
Enterprise Value to EBIT (EV/EBIT)	9.79	7.60	16.24	0.00	0.00	463.18	0.00	0.00	8.12	8.45	6.70
Enterprise Value to NOPAT (EV/NOPAT)	13.11	9.88	20.19	0.00	0.00	2,808.42	0.00	0.00	9.49	10.74	18.70
Enterprise Value to Operating Cash Flow (EV/OCF)	18.28	9.94	7.44	12.16	14.42	88.45	0.00	8.87	0.00	10.79	9.65
Enterprise Value to Free Cash Flow (EV/FCFF)	22.86	9.71	18.15	15.77	17.59	0.00	0.00	5.15	12.12	2.92	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.04
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.03
Financial Leverage	-0.27	-0.26	-0.30	-0.35	-0.38	-0.37	-0.35	-0.36	-0.38	-0.24	-0.02
Leverage Ratio	1.14	1.12	1.08	1.08	1.08	1.10	1.11	1.12	1.12	1.20	1.30
Compound Leverage Factor	1.15	1.12	1.11	1.02	1.02	4.08	1.08	1.12	1.06	1.17	1.38
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.28%	3.56%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.59%	1.05%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.69%	2.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	86.72%	96.44%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.40	0.20
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	-0.22
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.32	0.14
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.66	0.73
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30	-0.79
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.53	0.52
Altman Z-Score	12.19	16.56	15.74	12.63	8.87	11.29	8.00	5.72	8.60	6.06	4.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.67	11.15	10.41	10.09	10.46	9.08	10.09	7.96	8.57	3.67	3.94
Quick Ratio	3.39	6.95	6.28	6.85	7.61	6.68	7.05	5.97	6.02	1.60	1.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	119	195	101	83	37	-13	-48	66	52	280	-515
Operating Cash Flow to CapEx	359.18%	713.39%	970.33%	441.65%	299.89%	173.27%	-374.70%	1,198.25%	-67.51%	538.92%	903.05%
Free Cash Flow to Firm to Interest Expense	3,411.85	16,221.12	3,606.97	1,156.26	128.19	-42.14	-77.79	312.18	12.77	50.90	-212.10
Operating Cash Flow to Interest Expense	4,266.09	15,846.25	8,804.36	1,499.90	156.37	46.75	-33.96	181.26	-1.44	13.78	38.45
Operating Cash Flow Less CapEx to Interest Expense	3,078.34	13,625.00	7,897.00	1,160.29	104.23	19.77	-43.02	166.14	-3.57	11.22	34.19
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.59	0.37	0.32	0.30	0.35	0.31	0.30	0.47	0.77	0.79
Accounts Receivable Turnover	2.85	2.43	2.02	2.25	1.95	1.84	1.45	1.40	2.13	3.14	3.69
Inventory Turnover	1.35	1.25	0.94	1.02	1.22	1.49	1.29	1.73	2.12	2.51	2.08
Fixed Asset Turnover	3.03	2.80	1.75	1.50	1.38	1.56	1.48	1.43	2.35	4.75	5.43
Accounts Payable Turnover	10.34	10.84	9.80	9.49	9.76	8.08	6.44	8.51	7.90	9.60	8.81
Days Sales Outstanding (DSO)	128.06	149.96	180.66	162.33	186.85	198.13	252.36	260.41	171.44	116.18	98.84
Days Inventory Outstanding (DIO)	270.42	292.86	388.93	357.27	299.81	245.14	282.58	211.41	172.26	145.55	175.76
Days Payable Outstanding (DPO)	35.29	33.68	37.26	38.46	37.41	45.17	56.67	42.87	46.21	38.04	41.45
Cash Conversion Cycle (CCC)	363.19	409.13	532.33	481.15	449.25	398.09	478.27	428.95	297.49	223.69	233.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	946	943	933	801	678	692	696	542	556	352	915
Invested Capital Turnover	1.03	0.89	0.57	0.53	0.52	0.61	0.53	0.52	0.85	1.22	1.04
Increase / (Decrease) in Invested Capital	89	-3.37	-10	-132	-123	14	3.82	-154	14	-204	564
Enterprise Value (EV)	2,730	1,890	1,833	1,313	656	1,298	694	341	625	818	902
Market Capitalization	3,029	2,272	2,257	1,806	1,074	1,697	1,040	696	922	795	939
Book Value per Share	$31.55	$34.53	$36.09	$34.19	$30.64	$30.15	$29.68	$25.35	$25.72	$9.62	$14.25
Tangible Book Value per Share	$31.55	$34.53	$34.39	$31.92	$29.45	$29.04	$28.84	$24.60	$25.03	$7.70	$11.74
Total Capital	1,245	1,324	1,356	1,294	1,096	1,091	1,042	897	872	379	994
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	50	35
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	41	25
Net Debt	-299	-381	-423	-493	-418	-399	-346	-355	-297	23	-38
Capital Expenditures (CapEx)	42	27	25	24	15	8.47	5.63	3.21	8.61	14	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	630	642	532	415	353	385	432	296	365	212	416
Debt-free Net Working Capital (DFNWC)	928	1,023	955	909	771	784	778	652	662	219	489
Net Working Capital (NWC)	928	1,023	955	909	771	784	778	652	662	210	479
Net Nonoperating Expense (NNE)	-0.47	-0.72	-2.42	52	9.78	-1.26	-14	41	2.53	2.28	-92
Net Nonoperating Obligations (NNO)	-299	-381	-423	-493	-418	-399	-346	-355	-316	23	-43
Total Depreciation and Amortization (D&A)	31	30	32	41	35	34	32	30	25	30	40
Debt-free, Cash-free Net Working Capital to Revenue	67.65%	76.06%	98.70%	91.22%	91.87%	92.72%	118.29%	91.93%	78.22%	38.17%	62.94%
Debt-free Net Working Capital to Revenue	99.74%	121.22%	177.31%	199.50%	200.57%	188.90%	213.08%	202.17%	141.80%	39.51%	74.03%
Net Working Capital to Revenue	99.74%	121.22%	177.31%	199.50%	200.57%	188.90%	213.08%	202.17%	141.80%	37.74%	72.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.22	$5.00	$2.48	($2.69)	($2.58)	$0.05	($0.87)	($3.62)	$0.01	$0.00	$2.82
Adjusted Weighted Average Basic Shares Outstanding	39.96M	38.36M	37.54M	37.46M	37.08M	35.84M	35.26M	35.33M	34.24M	0.00	49.73M
Adjusted Diluted Earnings per Share	$5.19	$4.98	$2.47	($2.69)	($2.58)	$0.05	($0.87)	($3.62)	$0.01	$0.00	$2.77
Adjusted Weighted Average Diluted Shares Outstanding	40.19M	38.53M	37.67M	37.46M	37.08M	36.15M	35.26M	35.33M	34.47M	0.00	50.63M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	38.77M	37.95M	37.81M	38.14M	36.39M	35.87M	35.43M	34.79M	34.17M	0.00	69.26M
Normalized Net Operating Profit after Tax (NOPAT)	208	191	91	-5.84	-21	3.98	-15	-82	67	77	51
Normalized NOPAT Margin	22.37%	22.66%	16.84%	-1.28%	-5.52%	0.96%	-4.04%	-25.57%	14.40%	13.77%	7.72%
Pre Tax Income Margin	30.01%	29.58%	21.51%	-14.41%	-29.90%	2.51%	-17.00%	-38.94%	15.61%	16.99%	21.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7,964.23	20,736.25	4,030.68	-960.22	-421.78	8.93	-102.35	-591.20	19.08	17.60	55.39
NOPAT to Interest Expense	5,949.71	15,940.71	3,242.86	-672.16	-295.25	1.47	-71.64	-413.84	16.31	13.84	19.84
EBIT Less CapEx to Interest Expense	6,776.49	18,515.00	3,123.32	-1,299.83	-473.92	-18.05	-111.41	-606.33	16.94	15.04	51.13
NOPAT Less CapEx to Interest Expense	4,761.97	13,719.46	2,335.50	-1,011.77	-347.39	-25.51	-80.71	-428.97	14.18	11.28	15.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	53.44%
Augmented Payout Ratio	91.15%	39.48%	26.00%	0.00%	-104.50%	1,544.77%	-81.25%	-18.83%	2.04%	0.00%	53.44%

This table displays calculated financial ratios and metrics derived from Innovex International's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.20%	6,070.82%	9.30%	-4.65%	57.80%	16.86%	21.39%	34.30%	9.15%	17.95%
EBITDA Growth	1,930.53%	207.07%	412.04%	180.32%	36.34%	8.05%	-202.91%	-68.64%	209.24%	34.78%
EBIT Growth	279.22%	201.00%	157.02%	193.20%	93.23%	-8.73%	-689.77%	-229.40%	231.83%	28.95%
NOPAT Growth	368.35%	234.70%	131.72%	183.03%	21.66%	-13.45%	-1,160.24%	-245.24%	-186.08%	41.22%
Net Income Growth	219.26%	200.89%	125.86%	162.53%	15.63%	-18.19%	-964.73%	-152.02%	437.46%	50.73%
EPS Growth	222.58%	213.26%	126.92%	162.50%	26.32%	-20.00%	-928.57%	-150.00%	314.58%	-14.02%
Operating Cash Flow Growth	-88.82%	184.78%	-384.26%	221.56%	9,124.28%	60.12%	92.24%	-182.47%	-26.65%	69.96%
Free Cash Flow Firm Growth	28.20%	-48.02%	-169.59%	-188.31%	-240.93%	389.14%	26.24%	38.18%	-20.47%	-282.73%
Invested Capital Growth	-12.46%	2.64%	11.92%	16.30%	26.52%	-36.70%	5.57%	7.91%	20.37%	160.17%
Revenue Q/Q Growth	-6.21%	129.10%	-6.00%	-1.38%	55.22%	69.67%	-12.70%	9.11%	26.15%	83.34%
EBITDA Q/Q Growth	414.44%	252.81%	121.38%	5.74%	150.20%	179.61%	-179.50%	132.22%	2,367.49%	21.86%
EBIT Q/Q Growth	421.30%	486.21%	226.66%	13.11%	566.14%	176.87%	-512.60%	75.18%	1,808.32%	7.59%
NOPAT Q/Q Growth	581.08%	422.14%	4.85%	81.16%	604.86%	271.47%	-993.86%	75.18%	-317.78%	709.36%
Net Income Q/Q Growth	338.58%	385.34%	670.62%	50.71%	341.17%	243.39%	-1,183.73%	90.93%	4,657.73%	-3.69%
EPS Q/Q Growth	337.50%	439.47%	800.00%	42.86%	380.00%	241.67%	-1,066.67%	91.38%	4,080.00%	-29.15%
Operating Cash Flow Q/Q Growth	111.23%	1,181.77%	-200.61%	121.32%	751.95%	-77.75%	-115.71%	-126.71%	857.76%	-48.45%
Free Cash Flow Firm Q/Q Growth	-6.80%	-39.17%	-390.97%	-30.26%	-48.74%	311.13%	55.50%	-9.18%	-189.84%	-220.25%
Invested Capital Q/Q Growth	0.37%	5.04%	10.68%	-0.32%	9.19%	-47.45%	-2.17%	1.89%	21.80%	13.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	25.45%	45.67%	27.91%	26.67%	35.88%	40.80%	28.90%	30.84%	34.70%	39.86%
EBITDA Margin	22.18%	34.16%	11.09%	11.89%	19.17%	31.59%	-9.40%	2.78%	54.30%	36.09%
Operating Margin	14.10%	36.09%	3.51%	4.02%	17.24%	28.18%	-17.05%	-3.88%	-8.71%	30.81%
EBIT Margin	14.10%	36.09%	3.51%	4.02%	17.27%	28.18%	-17.05%	-3.88%	52.50%	30.81%
Profit (Net Income) Margin	15.08%	31.94%	2.54%	3.89%	11.05%	22.36%	-18.12%	-1.51%	54.40%	28.57%
Tax Burden Percent	104.81%	93.36%	38.94%	62.36%	66.10%	88.54%	120.34%	69.35%	103.23%	96.96%
Interest Burden Percent	102.00%	94.81%	186.17%	154.88%	96.78%	89.61%	88.32%	56.00%	100.36%	95.65%
Effective Tax Rate	-4.81%	6.64%	61.06%	37.64%	33.90%	11.47%	0.00%	0.00%	-3.23%	3.04%
Return on Invested Capital (ROIC)	6.83%	28.68%	0.87%	1.61%	7.91%	30.54%	-8.37%	-2.02%	-5.93%	31.15%
ROIC Less NNEP Spread (ROIC-NNEP)	6.75%	29.73%	0.51%	1.20%	8.09%	34.71%	-5.48%	-2.66%	-70.27%	67.86%
Return on Net Nonoperating Assets (RNNOA)	-2.60%	-11.29%	-0.17%	-0.42%	-2.50%	-8.48%	1.49%	0.70%	11.84%	-1.04%
Return on Equity (ROE)	4.23%	17.39%	0.69%	1.19%	5.41%	22.06%	-6.88%	-1.32%	5.91%	30.11%
Cash Return on Invested Capital (CROIC)	4.75%	9.39%	-10.30%	-12.89%	-20.67%	61.74%	-7.27%	-10.35%	-27.07%	-81.33%
Operating Return on Assets (OROA)	3.58%	17.03%	1.33%	1.51%	7.27%	21.67%	-7.57%	-1.85%	23.89%	24.34%
Return on Assets (ROA)	3.83%	15.07%	0.96%	1.45%	4.65%	17.19%	-8.05%	-0.72%	24.75%	22.58%
Return on Common Equity (ROCE)	4.23%	17.39%	0.69%	1.19%	5.41%	22.06%	-6.88%	-1.32%	5.91%	30.11%
Return on Equity Simple (ROE_SIMPLE)	-7.53%	0.00%	1.09%	2.12%	2.38%	0.00%	-2.53%	-3.17%	4.45%	0.00%
Net Operating Profit after Tax (NOPAT)	13	68	1.24	2.25	16	59	-13	-3.27	-14	83
NOPAT Margin	14.78%	33.69%	1.37%	2.51%	11.40%	24.95%	-11.93%	-2.71%	-8.99%	29.87%
Net Nonoperating Expense Percent (NNEP)	0.07%	-1.05%	0.35%	0.41%	-0.18%	-4.17%	-2.89%	0.64%	64.34%	-36.71%
Return On Investment Capital (ROIC_SIMPLE)	-	7.80%	-	-	-	15.52%	-	-	-	8.37%
Cost of Revenue to Revenue	74.55%	54.33%	72.09%	73.33%	64.12%	59.20%	71.10%	69.16%	65.30%	60.14%
SG&A Expenses to Revenue	25.45%	-4.03%	24.86%	24.68%	13.82%	3.76%	27.19%	24.74%	25.02%	6.62%
R&D to Revenue	3.00%	0.00%	3.74%	3.57%	0.00%	0.00%	3.39%	2.98%	0.00%	0.00%
Operating Expenses to Revenue	11.35%	9.59%	24.40%	22.64%	18.71%	12.57%	45.95%	34.72%	43.41%	9.05%
Earnings before Interest and Taxes (EBIT)	12	73	3.19	3.61	24	67	-19	-4.67	80	86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	20	69	10	11	27	75	-10	3.34	82	100
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.78	1.06	1.11	0.90	1.11	2.42	0.90	0.75	0.56	0.98
Price to Tangible Book Value (P/TBV)	0.80	1.09	1.14	0.93	1.19	3.02	0.96	0.80	0.60	1.19
Price to Revenue (P/Rev)	2.56	1.97	2.65	2.18	2.31	1.43	1.74	1.35	1.04	1.42
Price to Earnings (P/E)	0.00	14.56	101.86	42.57	48.23	10.76	0.00	0.00	12.33	6.69
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	6.87%	0.98%	2.35%	2.07%	9.29%	0.00%	0.00%	8.11%	14.94%
Enterprise Value to Invested Capital (EV/IC)	0.67	1.12	1.18	0.88	1.15	2.33	0.87	0.68	0.51	0.98
Enterprise Value to Revenue (EV/Rev)	1.36	1.34	1.96	1.48	1.86	1.47	1.27	0.95	0.84	1.36
Enterprise Value to EBITDA (EV/EBITDA)	0.00	6.11	19.12	12.04	14.89	6.43	37.20	57.50	0.00	5.17
Enterprise Value to EBIT (EV/EBIT)	0.00	8.12	78.64	32.32	27.35	8.45	0.00	0.00	0.00	6.70
Enterprise Value to NOPAT (EV/NOPAT)	0.00	9.49	131.39	43.36	46.94	10.74	0.00	0.00	0.00	18.70
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	20.96	10.79	9.97	12.54	39.55	9.65
Enterprise Value to Free Cash Flow (EV/FCFF)	13.21	12.12	0.00	0.00	0.00	2.92	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.00	0.03	0.04
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.01	0.03
Financial Leverage	-0.39	-0.38	-0.34	-0.35	-0.31	-0.24	-0.27	-0.26	-0.17	-0.02
Leverage Ratio	1.12	1.12	1.10	1.12	1.14	1.20	1.15	1.15	1.21	1.30
Compound Leverage Factor	1.14	1.06	2.06	1.73	1.10	1.08	1.01	0.64	1.21	1.24
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	13.28%	0.00%	0.00%	2.49%	3.56%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	2.59%	0.00%	0.00%	1.15%	1.05%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	10.69%	0.00%	0.00%	1.33%	2.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	86.72%	100.00%	100.00%	97.52%	96.44%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.40	0.00	0.00	-0.79	0.20
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.18	0.00	0.00	3.31	-0.22
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00	-0.42	0.14
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.66	0.00	0.00	-0.36	0.73
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00	1.53	-0.79
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.53	0.00	0.00	-0.19	0.52
Altman Z-Score	6.31	8.59	8.77	7.33	6.74	5.85	5.16	4.91	2.74	3.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.35	8.57	9.02	8.57	6.64	3.67	5.35	5.60	3.87	3.94
Quick Ratio	6.00	6.02	6.44	6.01	4.47	1.60	3.59	3.74	1.86	1.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	88	54	-64	-84	-125	263	-47	-52	-150	-480
Operating Cash Flow to CapEx	0.00%	99.44%	0.00%	119.93%	692.19%	2,607.93%	-93.66%	-154.45%	0.00%	564.98%
Free Cash Flow to Firm to Interest Expense	0.00	13.02	0.00	0.00	-82.15	30.17	0.00	0.00	-205.80	-80.75
Operating Cash Flow to Interest Expense	0.00	3.23	0.00	0.00	63.40	2.45	0.00	0.00	96.71	6.11
Operating Cash Flow Less CapEx to Interest Expense	0.00	-0.02	0.00	0.00	54.24	2.36	0.00	0.00	105.62	5.03
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.25	0.47	0.38	0.37	0.42	0.77	0.44	0.48	0.46	0.79
Accounts Receivable Turnover	1.20	2.13	1.55	1.49	1.64	3.14	1.59	1.69	1.90	3.69
Inventory Turnover	1.95	2.12	1.82	1.73	1.77	2.51	1.78	1.84	1.45	2.08
Fixed Asset Turnover	1.29	2.35	1.87	2.00	2.12	4.75	2.23	2.39	2.47	5.43
Accounts Payable Turnover	7.57	7.90	6.38	5.23	5.92	9.60	5.84	5.88	5.20	8.81
Days Sales Outstanding (DSO)	304.73	171.44	236.20	245.29	222.67	116.18	230.13	216.20	192.15	98.84
Days Inventory Outstanding (DIO)	186.83	172.26	200.66	210.78	205.91	145.55	205.50	198.82	251.49	175.76
Days Payable Outstanding (DPO)	48.20	46.21	57.19	69.74	61.65	38.04	62.52	62.06	70.13	41.45
Cash Conversion Cycle (CCC)	443.37	297.49	379.67	386.33	366.93	223.69	373.11	352.97	373.51	233.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	529	556	615	613	670	352	650	662	806	915
Invested Capital Turnover	0.46	0.85	0.63	0.64	0.69	1.22	0.70	0.74	0.66	1.04
Increase / (Decrease) in Invested Capital	-75	14	66	86	140	-204	34	48	136	564
Enterprise Value (EV)	355	625	726	540	773	818	564	451	409	902
Market Capitalization	671	922	980	795	963	795	770	640	506	939
Book Value per Share	$25.16	$25.72	$25.76	$25.73	$25.47	$9.62	$24.91	$24.77	$26.25	$14.25
Tangible Book Value per Share	$24.47	$25.03	$25.10	$25.09	$23.75	$7.70	$23.27	$23.17	$24.52	$11.74
Total Capital	865	872	880	879	870	379	857	853	927	994
Total Debt	0.00	0.00	0.00	0.00	0.00	50	0.00	0.00	23	35
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	41	0.00	0.00	12	25
Net Debt	-316	-297	-254	-255	-190	23	-206	-189	-97	-38
Capital Expenditures (CapEx)	-7.67	13	-10	9.41	14	0.82	4.38	6.02	-6.49	6.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	341	365	414	412	412	212	375	392	413	416
Debt-free Net Working Capital (DFNWC)	656	662	669	667	602	219	582	581	513	489
Net Working Capital (NWC)	656	662	669	667	602	210	582	581	503	479
Net Nonoperating Expense (NNE)	-0.26	3.53	-1.07	-1.23	0.49	6.12	6.82	-1.45	-96	3.62
Net Nonoperating Obligations (NNO)	-336	-316	-265	-266	-201	23	-208	-191	-98	-43
Total Depreciation and Amortization (D&A)	7.12	-3.88	6.89	7.05	2.64	8.03	8.43	8.01	2.73	15
Debt-free, Cash-free Net Working Capital to Revenue	130.18%	78.22%	112.13%	112.72%	99.06%	38.17%	84.62%	82.64%	84.88%	62.94%
Debt-free Net Working Capital to Revenue	250.68%	141.80%	180.91%	182.61%	144.71%	39.51%	131.14%	122.54%	105.39%	74.03%
Net Working Capital to Revenue	250.68%	141.80%	180.91%	182.61%	144.71%	37.74%	131.14%	122.54%	103.20%	72.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.45	$2.10	$0.07	$0.10	($0.21)	$1.72	($0.58)	($0.05)	$2.03	$1.42
Adjusted Weighted Average Basic Shares Outstanding	33.95M	30.54M	34.13M	34.13M	34.13M	30.93M	34.42M	34.44M	40.73M	49.73M
Adjusted Diluted Earnings per Share	$0.44	$2.05	$0.07	$0.10	($0.21)	$1.64	($0.58)	($0.05)	$1.99	$1.41
Adjusted Weighted Average Diluted Shares Outstanding	34.23M	31.44M	34.49M	34.49M	34.13M	32.34M	34.42M	34.44M	41.53M	50.63M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	33.92M	34.17M	34.17M	34.18M	34.18M	34.41M	34.42M	34.45M	67.25M	69.26M
Normalized Net Operating Profit after Tax (NOPAT)	-0.52	85	-1.22	1.41	16	59	-13	-3.23	-9.37	83
Normalized NOPAT Margin	-0.59%	42.23%	-1.34%	1.57%	11.52%	24.95%	-12.06%	-2.68%	-6.17%	29.75%
Pre Tax Income Margin	14.38%	34.21%	6.53%	6.23%	16.71%	25.26%	-15.06%	-2.17%	52.69%	29.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	17.65	0.00	0.00	15.85	7.63	0.00	0.00	109.34	14.41
NOPAT to Interest Expense	0.00	16.48	0.00	0.00	10.46	6.76	0.00	0.00	-18.72	13.97
EBIT Less CapEx to Interest Expense	0.00	14.40	0.00	0.00	6.69	7.54	0.00	0.00	118.25	13.33
NOPAT Less CapEx to Interest Expense	0.00	13.22	0.00	0.00	1.30	6.66	0.00	0.00	-9.81	12.89
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	53.44%
Augmented Payout Ratio	-67.34%	2.04%	155.83%	59.70%	0.00%	0.00%	0.00%	0.00%	0.00%	53.44%

Frequently Asked Questions About Innovex International's Financials

When does Innovex International's fiscal year end?

According to the most recent income statement we have on file, Innovex International's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Innovex International's net income changed over the last 10 years?

Innovex International's net income appears to be on a downward trend, with a most recent value of $140.33 million in 2024, falling from $208.71 million in 2014. The previous period was $73.93 million in 2023.

What is Innovex International's operating income?

Innovex International's total operating income in 2024 was $49.08 million, based on the following breakdown:

Total Gross Profit: $232.63 million
Total Operating Expenses: $183.56 million

How has Innovex International revenue changed over the last 10 years?

Over the last 10 years, Innovex International's total revenue changed from $930.96 million in 2014 to $660.80 million in 2024, a change of -29.0%.

How much debt does Innovex International have?

Innovex International's total liabilities were at $239.33 million at the end of 2024, a 63.5% increase from 2023, and a 17.3% increase since 2014.

How much cash does Innovex International have?

In the past 10 years, Innovex International's cash and equivalents has ranged from $7.41 million in 2023 to $493.18 million in 2017, and is currently $73.28 million as of their latest financial filing in 2024.

How has Innovex International's book value per share changed over the last 10 years?

Over the last 10 years, Innovex International's book value per share changed from 31.55 in 2014 to 14.25 in 2024, a change of -54.8%.

Related Companies

This page (NYSE:INVX) was last updated on 4/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innovex International (INVX) Financials

Frequently Asked Questions About Innovex International's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innovex International (INVX) Financials

Annual Income Statements for Innovex International

Quarterly Income Statements for Innovex International

Annual Cash Flow Statements for Innovex International

Quarterly Cash Flow Statements for Innovex International

Annual Balance Sheets for Innovex International

Quarterly Balance Sheets for Innovex International

Annual Metrics and Ratios for Innovex International

Quarterly Metrics and Ratios for Innovex International

Frequently Asked Questions About Innovex International's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools